2023 | November / December 2023

Manufacture of Sterile Medicinal Products – meeting EU GMP Annex 1 requirements

by cyb2025

ANNA CLUET
Pharmaceutical Consultant and Senior Auditor, Rephine, Spain

ABSTRACT

Now that the EU GMP Annex 1 requirements related to the Manufacture of Sterile Medicinal Products are live, the expectations of auditors have changed. Implementing fit-for-purpose Contamination Control Strategies is a challenge for many manufacturers. Anna Cluet of Rephine sets out how to identify compliance gaps and offers suggestions as to how to resolve them.

In August, the revised EU GMP Annex 1 requirements related to the Manufacture of Sterile Medicinal Products came into force, with implications for contamination control strategies and, by extension, for plant facilities, equipment, manufacturing processes and Quality systems.

Login